Mitsubishi Tanabe Sales Director Aims For Top Of Japan’s Diabetes Market
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharmaceuticals Managing Executive Director and Head of Sales Kenichi Yanagisawa held a press conference in Tokyo Aug. 31 regarding the DPP-4 inhibitor Teneria to be released Sept. 10.